Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 557

1.

Upregulation of SPDEF is associated with poor prognosis in prostate cancer.

Meiners J, Schulz K, Möller K, Höflmayer D, Burdelski C, Hube-Magg C, Simon R, Göbel C, Hinsch A, Reiswich V, Weidemann S, Izbicki JR, Sauter G, Jacobsen F, Möller-Koop C, Mandelkow T, Blessin NC, Lutz F, Viehweger F, Lennartz M, Fraune C, Heinzer H, Minner S, Bonk S, Huland H, Graefen M, Schlomm T, Büscheck F.

Oncol Lett. 2019 Nov;18(5):5107-5118. doi: 10.3892/ol.2019.10885. Epub 2019 Sep 19.

2.

Up regulation of Rho-associated coiled-coil containing kinase1 (ROCK1) is associated with genetic instability and poor prognosis in prostate cancer.

Steurer S, Hager B, Büscheck F, Höflmayer D, Tsourlakis MC, Minner S, Clauditz TS, Hube-Magg C, Luebke AM, Simon R, Izbicki JR, Burandt E, Sauter G, Fraune C, Weidemann S, Schlomm T, Heinzer H, Haese A, Graefen M, Huland H, Heumann A.

Aging (Albany NY). 2019 Sep 25;11(18):7859-7879. doi: 10.18632/aging.102294. Epub 2019 Sep 25.

3.

Prognostic and diagnostic role of PSA immunohistochemistry: A tissue microarray study on 21,000 normal and cancerous tissues.

Bonk S, Kluth M, Hube-Magg C, Polonski A, Soekeland G, Makropidi-Fraune G, Möller-Koop C, Witt M, Luebke AM, Hinsch A, Burandt E, Steurer S, Clauditz TS, Schlomm T, Perez D, Graefen M, Heinzer H, Huland H, Izbicki JR, Wilczak W, Minner S, Sauter G, Simon R.

Oncotarget. 2019 Sep 10;10(52):5439-5453. doi: 10.18632/oncotarget.27145. eCollection 2019 Sep 10.

4.

Letter to Editor Reply to: "Centralization of Pancreatic Surgery in Europe: an Update".

Uzunoglu FG, Heumann A, Polonski A, Izbicki JR.

J Gastrointest Surg. 2019 Sep 11. doi: 10.1007/s11605-019-04387-7. [Epub ahead of print] No abstract available.

PMID:
31512102
5.

Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial.

Jones RP, Psarelli EE, Jackson R, Ghaneh P, Halloran CM, Palmer DH, Campbell F, Valle JW, Faluyi O, O'Reilly DA, Cunningham D, Wadsley J, Darby S, Meyer T, Gillmore R, Anthoney A, Lind P, Glimelius B, Falk S, Izbicki JR, Middleton GW, Cummins S, Ross PJ, Wasan H, McDonald A, Crosby T, Ting Y, Patel K, Sherriff D, Soomal R, Borg D, Sothi S, Hammel P, Lerch MM, Mayerle J, Tjaden C, Strobel O, Hackert T, Büchler MW, Neoptolemos JP; European Study Group for Pancreatic Cancer.

JAMA Surg. 2019 Sep 4. doi: 10.1001/jamasurg.2019.3337. [Epub ahead of print]

PMID:
31483448
6.

[Fluorescence angiography for esophageal anastomoses : Perfusion evaluation of the gastric conduit with indocyanine green].

Duprée A, von Kroge PH, Izbicki JR, Wipper SH, Mann O.

Chirurg. 2019 Aug 30. doi: 10.1007/s00104-019-01021-9. [Epub ahead of print] Review. German.

PMID:
31471660
7.

Microbial findings, sensitivity and outcome in patients with postoperative peritonitis a retrospective cohort study.

Grotelueschen R, Luetgehetmann M, Erbes J, Heidelmann LM, Grupp K, Karstens K, Ghadban T, Reeh M, Izbicki JR, Bachmann K.

Int J Surg. 2019 Oct;70:63-69. doi: 10.1016/j.ijsu.2019.08.020. Epub 2019 Aug 19.

PMID:
31437641
8.

A hairy cavity: endoscopic therapy of a presacral recurrence of a complex pilonidal sinus.

Noorah A, Bellon E, Izbicki JR, Tachezy M, Kantowski M.

Int J Colorectal Dis. 2019 Oct;34(10):1791-1794. doi: 10.1007/s00384-019-03366-3. Epub 2019 Aug 21.

PMID:
31435733
9.

Expression of the immune checkpoint receptor TIGIT in seminoma.

Hinsch A, Blessin NC, Simon R, Kluth M, Fischer K, Hube-Magg C, Li W, Makrypidi-Fraune G, Wellge B, Mandelkow T, Debatin NF, Höflmayer D, Lennartz M, Sauter G, Izbicki JR, Minner S, Büscheck F, Uhlig R, Dum D, Krech T, Luebke AM, Wittmer C, Jacobsen F, Burandt E, Steurer S, Wilczak W.

Oncol Lett. 2019 Aug;18(2):1497-1502. doi: 10.3892/ol.2019.10428. Epub 2019 May 31.

10.

Protein expression of close homologue of L1 (CHL1) is a marker for overall survival in non-small cell lung cancer (NSCLC).

Hötzel J, Melling N, Müller J, Polonski A, Wolters-Eisfeld G, Izbicki JR, Karstens KF, Tachezy M.

J Cancer Res Clin Oncol. 2019 Sep;145(9):2285-2292. doi: 10.1007/s00432-019-02989-x. Epub 2019 Aug 1.

PMID:
31372722
11.

Morphologic Factors Predict Pain Relief Following Pancreatic Head Resection in Chronic Pancreatitis Description of the Chronic Pancreatitis Pain Relief (CPPR) Score.

Bachmann K, Melling N, Groteluschen R, Fleischauer A, Reeh M, Ghadban T, Bockhorn M, Izbicki JR.

Ann Surg. 2019 Jul 23. doi: 10.1097/SLA.0000000000003439. [Epub ahead of print]

PMID:
31348039
12.
13.

Clinical outcome of patients undergoing abdominoplasty after massive weight loss.

Hunecke P, Toll M, Mann O, Izbicki JR, Blessmann M, Grupp K.

Surg Obes Relat Dis. 2019 Aug;15(8):1362-1366. doi: 10.1016/j.soard.2019.06.001. Epub 2019 Jun 12.

14.

Biperiden and mepazine effectively inhibit MALT1 activity and tumor growth in pancreatic cancer.

Konczalla L, Perez DR, Wenzel N, Wolters-Eisfeld G, Klemp C, Lüddeke J, Wolski A, Landschulze D, Meier C, Buchholz A, Yao D, Hofmann BT, Graß JK, Spriestersbach SL, Grupp K, Schumacher U, Betzel C, Kapis S, Nuguid T, Steinberg P, Püschel K, Sauter G, Bockhorn M, Uzunoglu FG, Izbicki JR, Güngör C, El Gammal AT.

Int J Cancer. 2019 Jul 10. doi: 10.1002/ijc.32567. [Epub ahead of print]

PMID:
31291468
15.

Aberrant expression of Sec61α in esophageal cancers.

Bachmann K, Bockhorn M, Mann O, Gebauer F, Blessmann M, Izbicki JR, Grupp K.

J Cancer Res Clin Oncol. 2019 Aug;145(8):2039-2044. doi: 10.1007/s00432-019-02955-7. Epub 2019 Jun 13.

PMID:
31197453
16.

Immune Exclusion Is Frequent in Small-Cell Carcinoma of the Bladder.

Mandelkow T, Blessin NC, Lueerss E, Pott L, Simon R, Li W, Wellge B, Debatin NF, Höflmayer D, Izbicki JR, Büscheck F, Luebke AM, Wittmer C, Jacobsen F, Lutz F, Burandt E, Steurer S, Sauter G, Tsourlakis MC, Wilczak W, Hinsch A, Minner S.

Dis Markers. 2019 May 2;2019:2532518. doi: 10.1155/2019/2532518. eCollection 2019.

17.

Prospective Comparison of the Prognostic Relevance of Circulating Tumor Cells in Blood and Disseminated Tumor Cells in Bone Marrow of a Single Patient's Cohort With Esophageal Cancer.

Konczalla L, Ghadban T, Effenberger KE, Wöstemeier A, Riethdorf S, Uzunoglu FG, Izbicki JR, Pantel K, Bockhorn M, Reeh M.

Ann Surg. 2019 Jun 7. doi: 10.1097/SLA.0000000000003406. [Epub ahead of print]

PMID:
31188197
18.

Cholecystokinin-8 treatment reduces acinar necrosis and edema of pigs with induced pancreatitis.

Grupp K, Bonk S, Poppe A, Wodack K, Reeh M, Gocht A, Mann O, Izbicki JR, Bachmann K.

Asian J Surg. 2019 Jun 3. pii: S1015-9584(19)30013-2. doi: 10.1016/j.asjsur.2019.05.002. [Epub ahead of print]

19.

[Standardized access options for colorectal surgery with the da Vinci Xi system].

Perez D, Woestemeier A, Ghadban T, Stein H, Gomez-Ruiz M, Izbicki JR, Soh Min B.

Chirurg. 2019 May 14. doi: 10.1007/s00104-019-0973-6. [Epub ahead of print] Review. German.

PMID:
31089749
20.

Extended cycle streptozotocin/5-FU chemotherapy for maintenance therapy in pancreatic neuroendocrine tumors.

Schrader J, Henes FO, Blaeker M, Zimmermann-Fraedrich K, Pace A, Perez D, Izbicki JR, Lohse AW, Benten D.

Endocrine. 2019 Aug;65(2):460-467. doi: 10.1007/s12020-019-01941-w. Epub 2019 Apr 29.

PMID:
31037707
21.

Centralization of Pancreatic Surgery in Europe.

Polonski A, Izbicki JR, Uzunoglu FG.

J Gastrointest Surg. 2019 Oct;23(10):2081-2092. doi: 10.1007/s11605-019-04215-y. Epub 2019 Apr 29.

PMID:
31037503
22.

Melatonin treatment of pigs with acute pancreatitis reduces inflammatory reaction of pancreatic tissue and enhances fitness score of pigs: experimental research.

Grupp K, Erbes J, Poppe A, Wodack K, Gocht A, Trepte C, Havel J, Mann O, Izbicki JR, Bachmann K.

World J Emerg Surg. 2019 Apr 11;14:18. doi: 10.1186/s13017-019-0237-2. eCollection 2019.

23.

Decentralized colorectal cancer care in Germany over the last decade is associated with high in-hospital morbidity and mortality.

Ghadban T, Reeh M, Bockhorn M, Grotelueschen R, Bachmann K, Grupp K, Uzunoglu FG, Izbicki JR, Perez DR.

Cancer Manag Res. 2019 Mar 12;11:2101-2107. doi: 10.2147/CMAR.S197865. eCollection 2019.

24.

Increase of CD45-positive Immune Cells in Liver Parenchyma Indicates a More Favorable Prognosis for Patients With Barrett's Cancer.

Kemper M, Strohm T, Grupp K, Ghadban T, Bogoevski D, Bachmann K, Bockhorn M, Sauter G, Izbicki JR, Reeh M.

Anticancer Res. 2019 Mar;39(3):1191-1196. doi: 10.21873/anticanres.13229.

PMID:
30842149
25.

Successful Use of the Recanalized Remnant Umbilical Vein as a Patch Graft for Venous Reconstruction in Abdominal Surgery.

Stüben BO, Heumann A, Stürznickel J, Izbicki JR, Li J.

J Gastrointest Surg. 2019 Jun;23(6):1227-1231. doi: 10.1007/s11605-019-04150-y. Epub 2019 Feb 19.

PMID:
30783956
26.

Prevalence and clinical significance of RBM3 immunostaining in non-small cell lung cancers.

Melling N, Bachmann K, Hofmann B, El Gammal AT, Reeh M, Mann O, Moebius C, Blessmann M, Izbicki JR, Grupp K.

J Cancer Res Clin Oncol. 2019 Apr;145(4):873-879. doi: 10.1007/s00432-019-02850-1. Epub 2019 Feb 13.

PMID:
30758670
27.

What predicts the outcome in patients with intestinal ischemia? A single center experience.

Grotelüschen R, Bergmann W, Welte MN, Reeh M, Izbicki JR, Bachmann K.

J Visc Surg. 2019 Feb 8. pii: S1878-7886(19)30007-4. doi: 10.1016/j.jviscsurg.2019.01.007. [Epub ahead of print]

PMID:
30745185
28.

Patterns of TIGIT Expression in Lymphatic Tissue, Inflammation, and Cancer.

Blessin NC, Simon R, Kluth M, Fischer K, Hube-Magg C, Li W, Makrypidi-Fraune G, Wellge B, Mandelkow T, Debatin NF, Höflmayer D, Lennartz M, Sauter G, Izbicki JR, Minner S, Büscheck F, Uhlig R, Dum D, Krech T, Luebke AM, Wittmer C, Jacobsen F, Burandt EC, Steurer S, Wilczak W, Hinsch A.

Dis Markers. 2019 Jan 10;2019:5160565. doi: 10.1155/2019/5160565. eCollection 2019.

29.

No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study.

Dong J, Gharahkhani P, Chow WH, Gammon MD, Liu G, Caldas C, Wu AH, Ye W, Onstad L, Anderson LA, Bernstein L, Pharoah PD, Risch HA, Corley DA, Fitzgerald RC; Stomach and Esophageal Cancer Study Consortium, Iyer PG, Reid BJ, Lagergren J, Shaheen NJ, Vaughan TL, MacGregor S, Love S, Palles C, Tomlinson I, Gockel I, May A, Gerges C, Anders M, Böhmer AC, Becker J, Kreuser N, Thieme R, Noder T, Venerito M, Veits L, Schmidt T, Schmidt C, Izbicki JR, Hölscher AH, Lang H, Lorenz D, Schumacher B, Mayershofer R, Vashist Y, Ott K, Vieth M, Weismüller J, Nöthen MM, Moebus S, Knapp M, Peters WHM, Neuhaus H, Rösch T, Ell C, Jankowski J, Schumacher J, Neale RE, Whiteman DC, Thrift AP.

Clin Gastroenterol Hepatol. 2019 Oct;17(11):2227-2235.e1. doi: 10.1016/j.cgh.2019.01.041. Epub 2019 Feb 1.

PMID:
30716477
30.

High levels of RAI3 expression is linked to shortened survival in esophageal cancer patients.

El Gammal AT, Melling N, Reeh M, Gebauer F, Mann O, Perez D, Bockhorn M, Bachmann K, Izbicki JR, Grupp K.

Exp Mol Pathol. 2019 Apr;107:51-56. doi: 10.1016/j.yexmp.2019.01.013. Epub 2019 Jan 29.

PMID:
30707896
31.

Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma.

Obazee O, Archibugi L, Andriulli A, Soucek P, Małecka-Panas E, Ivanauskas A, Johnson T, Gazouli M, Pausch T, Lawlor RT, Cavestro GM, Milanetto AC, Di Leo M, Pasquali C, Hegyi P, Szentesi A, Radu CE, Gheorghe C, Theodoropoulos GE, Bergmann F, Brenner H, Vodickova L, Katzke V, Campa D, Strobel O, Kaiser J, Pezzilli R, Federici F, Mohelnikova-Duchonova B, Boggi U, Lemstrova R, Johansen JS, Bojesen SE, Chen I, Jensen BV, Capurso G, Pazienza V, Dervenis C, Sperti C, Mambrini A, Hackert T, Kaaks R, Basso D, Talar-Wojnarowska R, Maiello E, Izbicki JR, Cuk K, Saum KU, Cantore M, Kupcinskas J, Palmieri O, Delle Fave G, Landi S, Salvia R, Fogar P, Vashist YK, Scarpa A, Vodicka P, Tjaden C, Iskierka-Jazdzewska E, Canzian F.

Int J Cancer. 2019 Aug 1;145(3):686-693. doi: 10.1002/ijc.32127. Epub 2019 Feb 7.

PMID:
30672594
32.

Duodenum-preserving pancreatic head resection: A retrospective analysis of the Hamburg Modification.

Bellon E, Roswora MD, Melling N, Grotelueschen R, Grupp K, Reeh M, Ghadban T, Izbicki JR, Bachmann K.

Surgery. 2019 May;165(5):938-945. doi: 10.1016/j.surg.2018.11.009. Epub 2019 Jan 15.

PMID:
30658850
33.

[Evidence for standard surgical procedures: appendicitis, diverticulitis and cholecystitis].

Tachezy M, Izbicki JR.

Chirurg. 2019 May;90(5):351-356. doi: 10.1007/s00104-018-0779-y. Review. German.

PMID:
30635701
34.

Evaluation of the MDACC clinical classification system for pancreatic cancer patients in an European multicenter cohort.

Uzunoglu FG, Welte MN, Gavazzi F, Maggino L, Perinel J, Salvia R, Janot M, Reeh M, Perez D, Montorsi M, Zerbi A, Adham M, Uhl W, Bassi C, Izbicki JR, Malleo G, Bockhorn M.

Eur J Surg Oncol. 2019 May;45(5):793-799. doi: 10.1016/j.ejso.2018.12.012. Epub 2018 Dec 19.

PMID:
30585172
35.

Molecular and functional heterogeneity of IL-10-producing CD4+ T cells.

Brockmann L, Soukou S, Steglich B, Czarnewski P, Zhao L, Wende S, Bedke T, Ergen C, Manthey C, Agalioti T, Geffken M, Seiz O, Parigi SM, Sorini C, Geginat J, Fujio K, Jacobs T, Roesch T, Izbicki JR, Lohse AW, Flavell RA, Krebs C, Gustafsson JA, Antonson P, Roncarolo MG, Villablanca EJ, Gagliani N, Huber S.

Nat Commun. 2018 Dec 21;9(1):5457. doi: 10.1038/s41467-018-07581-4.

36.

High expression of class III β-tubulin in upper gastrointestinal cancer types.

Höflmayer D, Öztürk E, Schroeder C, Hube-Magg C, Blessin NC, Simon R, Lang DS, Neubauer E, Göbel C, Heinrich MC, Fraune C, Möller K, Armbrust M, Freytag M, Hinsch A, Lühr C, Noack M, Reiswich V, Weidemann S, Bockhorn M, Perez D, Izbicki JR, Sauter G, Jacobsen F.

Oncol Lett. 2018 Dec;16(6):7139-7145. doi: 10.3892/ol.2018.9502. Epub 2018 Sep 25.

37.

Expression of the immune checkpoint receptor TIGIT in Hodgkin's lymphoma.

Li W, Blessin NC, Simon R, Kluth M, Fischer K, Hube-Magg C, Makrypidi-Fraune G, Wellge B, Mandelkow T, Debatin NF, Pott L, Höflmayer D, Lennartz M, Sauter G, Izbicki JR, Minner S, Büscheck F, Uhlig R, Dum D, Krech T, Luebke AM, Wittmer C, Jacobsen F, Burandt E, Steurer S, Wilczak W, Hinsch A.

BMC Cancer. 2018 Dec 4;18(1):1209. doi: 10.1186/s12885-018-5111-1.

38.

FOXO1 overexpression and loss of pSerine256-FOXO1 expression predicts clinical outcome in esophageal adenocarcinomas.

Grupp K, Uzunoglu FG, Melling N, Hofmann B, El Gammal AT, Grotelüschen R, Heumann A, Bellon E, Reeh M, Wolters-Eisfeld G, Ghabdan T, Nentwich M, Bachmann K, Bockhorn M, Bogoevski D, Izbicki JR, Kutup A.

Sci Rep. 2018 Nov 26;8(1):17370. doi: 10.1038/s41598-018-35459-4.

39.

Systematic review analysis of robotic and transanal approaches in TME surgery- A systematic review of the current literature in regard to challenges in rectal cancer surgery.

Grass JK, Perez DR, Izbicki JR, Reeh M.

Eur J Surg Oncol. 2019 Apr;45(4):498-509. doi: 10.1016/j.ejso.2018.11.010. Epub 2018 Nov 15.

PMID:
30470529
40.

Genetic determinants of telomere length and risk of pancreatic cancer: A PANDoRA study.

Campa D, Matarazzi M, Greenhalf W, Bijlsma M, Saum KU, Pasquali C, van Laarhoven H, Szentesi A, Federici F, Vodicka P, Funel N, Pezzilli R, Bueno-de-Mesquita HB, Vodickova L, Basso D, Obazee O, Hackert T, Soucek P, Cuk K, Kaiser J, Sperti C, Lovecek M, Capurso G, Mohelnikova-Duchonova B, Khaw KT, König AK, Kupcinskas J, Kaaks R, Bambi F, Archibugi L, Mambrini A, Cavestro GM, Landi S, Hegyi P, Izbicki JR, Gioffreda D, Zambon CF, Tavano F, Talar-Wojnarowska R, Jamroziak K, Key TJ, Fave GD, Strobel O, Jonaitis L, Andriulli A, Lawlor RT, Pirozzi F, Katzke V, Valsuani C, Vashist YK, Brenner H, Canzian F.

Int J Cancer. 2019 Mar 15;144(6):1275-1283. doi: 10.1002/ijc.31928. Epub 2018 Nov 12.

PMID:
30325019
41.

Minimally invasive surgery for colorectal cancer remains underutilized in Germany despite its nationwide application over the last decade.

Ghadban T, Reeh M, Bockhorn M, Heumann A, Grotelueschen R, Bachmann K, Izbicki JR, Perez DR.

Sci Rep. 2018 Oct 11;8(1):15146. doi: 10.1038/s41598-018-33510-y.

42.

Loss of complex O-glycosylation impairs exocrine pancreatic function and induces MODY8-like diabetes in mice.

Wolters-Eisfeld G, Mercanoglu B, Hofmann BT, Wolpers T, Schnabel C, Harder S, Steffen P, Bachmann K, Steglich B, Schrader J, Gagliani N, Schlüter H, Güngör C, Izbicki JR, Wagener C, Bockhorn M.

Exp Mol Med. 2018 Oct 10;50(10):133. doi: 10.1038/s12276-018-0157-3.

43.

Absence of HER2 Expression of Circulating Tumor Cells in Patients with Non-Metastatic Esophageal Cancer.

Woestemeier A, Ghadban T, Riethdorf S, Harms-Effenberger K, Konczalla L, Uzunoglu FG, Izbicki JR, Pantel K, Bockhorn M, Reeh M.

Anticancer Res. 2018 Oct;38(10):5665-5669. doi: 10.21873/anticanres.12902.

PMID:
30275185
44.

Evidence for PTGER4, PSCA, and MBOAT7 as risk genes for gastric cancer on the genome and transcriptome level.

Heinrichs SKM, Hess T, Becker J, Hamann L, Vashist YK, Butterbach K, Schmidt T, Alakus H, Krasniuk I, Höblinger A, Lingohr P, Ludwig M, Hagel AF, Schildberg CW, Veits L, Gyvyte U, Weise K, Schüller V, Böhmer AC, Schröder J, Gehlen J, Kreuser N, Hofer S, Lang H, Lordick F, Malfertheiner P, Moehler M, Pech O, Vassos N, Rodermann E, Izbicki JR, Kruschewski M, Ott K, Schumann RR, Vieth M, Mangold E, Gasenko E, Kupcinskas L, Brenner H, Grimminger P, Bujanda L, Sopeña F, Espinel J, Thomson C, Pérez-Aísa Á, Campo R, Geijo F, Collette D, Bruns C, Messerle K, Gockel I, Nöthen MM, Lippert H, Ridwelski K, Lanas A, Keller G, Knapp M, Leja M, Kupcinskas J, García-González MA, Venerito M, Schumacher J.

Cancer Med. 2018 Oct;7(10):5057-5065. doi: 10.1002/cam4.1719. Epub 2018 Sep 6.

45.

Mentorship Programs in Bariatric Surgery Reduce Perioperative Complication Rate at Equal Short-Term Outcome-Results from the OPTIMIZE Trial.

Wolter S, Duprée A, ElGammal A, Runkel N, Heimbucher J, Izbicki JR, Mann O, Busch P.

Obes Surg. 2019 Jan;29(1):127-136. doi: 10.1007/s11695-018-3495-2.

PMID:
30187421
46.

Pancreatic Metastasis from Endometrial Carcinoma.

Ghandili S, Bardenhagen J, Izbicki JR.

J Gastrointest Surg. 2019 Feb;23(2):377-378. doi: 10.1007/s11605-018-3934-3. Epub 2018 Sep 4. No abstract available.

PMID:
30187318
47.

Kidney Transplantation after Extended Multivisceral Resection for Pancreatic Ductal Adenocarcinoma.

Lapshyn H, Bolm L, Nitschke M, Luebke AM, Izbicki JR, Vashist YK, Keck T, Wellner UF.

Case Rep Transplant. 2018 Jul 26;2018:3757382. doi: 10.1155/2018/3757382. eCollection 2018.

48.

Author Correction: Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer.

Heumann A, Kaya Ö, Burdelski C, Hube-Magg C, Kluth M, Lang DS, Simon R, Beyer B, Thederan I, Sauter G, Izbicki JR, Luebke AM, Hinsch A, Jacobsen F, Wittmer C, Büscheck F, Höflmayer D, Minner S, Tsourlakis MC, Schlomm T, Wilczak W.

Sci Rep. 2018 Aug 21;8(1):12821. doi: 10.1038/s41598-018-30975-9.

49.

Nutritional support and therapy in pancreatic surgery: A position paper of the International Study Group on Pancreatic Surgery (ISGPS).

Gianotti L, Besselink MG, Sandini M, Hackert T, Conlon K, Gerritsen A, Griffin O, Fingerhut A, Probst P, Abu Hilal M, Marchegiani G, Nappo G, Zerbi A, Amodio A, Perinel J, Adham M, Raimondo M, Asbun HJ, Sato A, Takaori K, Shrikhande SV, Del Chiaro M, Bockhorn M, Izbicki JR, Dervenis C, Charnley RM, Martignoni ME, Friess H, de Pretis N, Radenkovic D, Montorsi M, Sarr MG, Vollmer CM, Frulloni L, Büchler MW, Bassi C.

Surgery. 2018 Nov;164(5):1035-1048. doi: 10.1016/j.surg.2018.05.040. Epub 2018 Jul 17.

PMID:
30029989
50.

Surgical Treatment of Chronic Pancreatitis: The State of the Art.

Kemper M, Izbicki JR, Bachmann K.

Chirurgia (Bucur). 2018 May-Jun;113(3):300-306. doi: 10.21614/chirurgia.113.3.300. Review.

Supplemental Content

Loading ...
Support Center